Patients with immune mediated inflammatory diseases are insufficiently protected against vaccine-preventable infections.

ABSTRACT:

Background

Patients with Immune Mediated Inflammatory Diseases (IMIDs) using immunosuppressive therapy are at increased risk of infections, including vaccine-preventable infections. In this study, we aimed to evaluate whether patients with IMIDs on systemic immunosuppressive therapy are vaccinated according to current guidelines.

Methods

A survey was sent out, between August 2022 and March 2023, to all patients with IMIDs that visited the departments of dermatology, rheumatology and gastroenterology at an academic and regional hospital in Rotterdam, the Netherlands. Patient-reported vaccination status was compared to the Dutch guidelines on vaccinations in patients with chronic inflammatory diseases.

Results

A total of 1,905/5,987 patients responded to the survey (res

SUBMITTER: van de Pol N 

PROVIDER: S-EPMC11825543 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature